journal article·2016-01-13

Antimicrobial Cellobiose Dehydrogenase-Chitosan Particles

Gregor Tegl, Barbara Thallinger, Bianca Beer, Christoph Sygmund, Roland Ludwig, Alexandra Rollett, Gibson S. Nyanhongo, Georg M. Guebitz

Publisher page

Abstract

Increasing prevalence of chronic wounds and microbial infection constitute a severe health challenge. The situation is further complicated by emerging multidrug resistance making the treatment of infections increasingly difficult. Here, a novel antimicrobial system based on in situ release of hydrogen peroxide (H2O2) by cellobiose dehydrogenase (CDH) immobilized on chitosan (CTS) particles is described. Covalent immobilization using carbodiimide coupling lead to a higher amount of protein immobilized on CTS (104 μg CDH/mg CTS) when compared to noncovalent immobilization, which, however, showed highest recovery of CDH activity (0.01 U/mg CTS). The CDH-CTS in situ generated H2O2 completely inhibited growth of Escherichia coli and Staphylococcus aureus over a period of 24 h. This resilient antimicrobial system represents a novel strategy for preventing infection with potential application in counteracting microbial colonization of chronic wounds.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antimicrobial agents and applications · Electrospun Nanofibers in Biomedical Applications · Wound Healing and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Environmental Biotechnology, BOKU−University of Natural Resources and Life Sciences, Vienna, Konrad Lorenz Straße 20, 3430 Tulln an der Donau, Austria

Department of Food Science and Technology, BOKU−University of Natural Resources and Life Sciences, Muthgasse 18, 1190 Vienna, Austria

Botswana International University of Science and Technology, Private Bag 16, Palapye, Botswana

ACIB−Austrian Centre of Industrial Biotechnology, Konrad Lorenz Straße 20, 3430 Tulln, Austria

Funding

Austrian Centre of Industrial Biotechnology · Seventh Framework Programme

References (25)

Show source-provided references
1. 10.1111/j.1524-475X.2009.00543.x10.1111/j.1524-475X.2009.00543.x ↗
2. 10.1046/j.1524-475x.2001.00178.x10.1046/j.1524-475x.2001.00178.x ↗
3. 10.1016/j.msec.2014.12.06810.1016/j.msec.2014.12.068 ↗
4. 10.1155/2012/19043610.1155/2012/190436 ↗
5. 10.1046/j.1524-475X.11.s2.1.x10.1046/j.1524-475X.11.s2.1.x ↗
6. 10.1016/j.burns.2003.09.03010.1016/j.burns.2003.09.030 ↗
7. 10.1086/64473210.1086/644732 ↗
8. Cooper, R.A review of the evidence for the use of topical antimicrobial agents in wound carehttp://www.worldwidewounds.com/2004/february/Cooper/Topical-Antimicrobial-Agents.html(accessed Jan 16, 2015) .
9. 10.1016/j.foodhyd.2012.02.01310.1016/j.foodhyd.2012.02.013 ↗
10. 10.1016/j.enzmictec.2003.12.01310.1016/j.enzmictec.2003.12.013 ↗
11. 10.1007/s00253-009-2062-010.1007/s00253-009-2062-0 ↗
12. 10.1016/j.enzmictec.2012.10.00710.1016/j.enzmictec.2012.10.007 ↗
13. 10.1002/jbm.b.3349110.1002/jbm.b.33491 ↗
14. 10.1016/j.ijantimicag.2014.06.01610.1016/j.ijantimicag.2014.06.016 ↗
15. 10.1039/C5TB00671F10.1039/C5TB00671F ↗
16. 10.1002/biot.20120031310.1002/biot.201200313 ↗
17. 10.1016/S0167-7012(00)00241-410.1016/S0167-7012(00)00241-4 ↗
18. 10.1039/B711564B10.1039/B711564B ↗
19. 10.1002/mabi.20030001110.1002/mabi.200300011 ↗
20. 10.1016/j.carbpol.2006.07.00810.1016/j.carbpol.2006.07.008 ↗
21. 10.1007/s12010-008-8148-910.1007/s12010-008-8148-9 ↗
22. 10.1016/S0003-4975(99)00832-210.1016/S0003-4975(99)00832-2 ↗
23. 10.1007/s13205-012-0071-710.1007/s13205-012-0071-7 ↗
24. 10.2174/13892030677745236710.2174/138920306777452367 ↗
25. 10.1146/annurev.micro.57.030502.09093810.1146/annurev.micro.57.030502.090938 ↗